Clinical Trial Update: Secretin Infusion to Prevent Pancreatic Leaks Following Pancreatic Resection [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating secretin infusion to prevent pancreatic leaks after pancreatic resection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Injury of Body of Pancreas
• Pancreatic Injuries

Drugs mentioned

• Secretin (secretin)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Injury of Body of Pancreas | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-03-31